Determination of lung as the primary site of cerebral metastatic adenocarcinomas using monoclonal antibody to thyroid transcription factor-1
- 1 January 1998
- journal article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 40 (3) , 227-231
- https://doi.org/10.1023/a:1006102607697
Abstract
Determining the primary site of a cerebral metastatic adenocarcinoma is complicated by the histologic similarity of most adenocarcinomas. Thyroid Transcription Factor-1 (TTF-1) is a highly specific...Keywords
This publication has 14 references indexed in Scilit:
- Metastatic adenocarcinoma to the brain: An immunohistochemical approachHuman Pathology, 1997
- Brain metastases from an unknown primary tumour: which diagnostic procedures are indicated?Journal of Neurology, Neurosurgery & Psychiatry, 1996
- Surfactant proteins and thyroid transcription factor-1 in pulmonary and breast carcinomas.1996
- Monoclonal Antibody to Thyroid Transcription Factor-1: Production, Characterization, and Usefulness in Tumor DiagnosisHybridoma, 1996
- Single brain metastases from unknown primary malignancies in CT-eraJournal of Neuro-Oncology, 1995
- The lung-specific surfactant protein B gene promoter is a target for thyroid transcription factor 1 and hepatocyte nuclear factor 3, indicating common factors for organ-specific gene expression along the foregut axis.Molecular and Cellular Biology, 1994
- Adenocarcinoma in the Lung in Patients With Breast Cancer:A Prospective Analysis of the Discriminatory Value of ImmunohistologyAmerican Journal of Clinical Pathology, 1993
- The transcription factor TTF-1 is expressed at the onset of thyroid and lung morphogenesis and in restricted regions of the foetal brainDevelopment, 1991
- Distribution of Brain MetastasesArchives of Neurology, 1988
- The contribution of immunohistochemical staining in tumour diagnosisHistopathology, 1987